Sero-prevalence of Human Immunodeficiency Virus and hepatitis viruses and their correlation with CD4 T-cell lymphocyte counts in pregnant women in the Buea Health District of Cameroon
Abstract
Prior to this study, very few studies in Cameroon have addressed co-infection of HIV and hepatitis in pregnancy. The aim of this study was to screen pregnant women living in the Buea Health District for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C virus (HCV) and determine how the prevalence of mono and co-infections relates to immunity. Eligible and consenting women were interviewed using a standardized questionnaire. After which 10 ml of whole blood was collected from 406 pregnant women. All specimens were tested for HIV, HBV and HCV using Determine HIV1/2 (Abbott Co. Ltd., Japan), SD Bioline (Standard Diagnostics, INC., USA) and ELISA (Murex Biotech Limited, Temple Hill, UK; ABBOTT Laboratories, Wiesbaden, Germany). The prevalence of HIV, HBV and HCV mono-infection in this study was 34(8.37%), 40(12.1%) and 28(6.89%) respectively. HIV/HBV, HIV/HCV, HBV/HCV and HIV/HBV/HCV multiple infection rates were 6(1.48%), 7(1.72%), 5(1.23%) and 2(0.49%) respectively and there was no statistical association between accessed risk factors and multiple viral infections in Pregnancy. Amongst women with a positive HIV result, those co-infected with HBV and HCV had the least mean CD4+ Tcell lymphocyte counts (531.50 ± 6.18) while those infected only with HIV had the highest mean CD4+ T-cell lymphocyte counts (620.22 ± 165.27). Co infection of HIV, HBV and HCV reduced the immune competence- CD4+ T cell counts, in pregnant women more than those who were HIV mono-infected.
© 2016 International Formulae Group. All rights reserved
Keywords: Mono-infection, multiple-infections, mother-to-child-transmission, CD4 T-cell lymphocyte, pregnancy
Submission of a paper for publication implies the transfer of the copyright from the author(s) to the publisher upon acceptance. International Formulae Group is therefore the copyright holder after publication of an article in International Journal of Biological and Chemical Sciences, and published articles should not be used for commercial purpose without the written consent of the Editor-in-Chief. They are licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.